Voting Rights Announcements | 10 December 2012 10:45
STRATEC Biomedical AG
10.12.2012 10:45
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to sec. 21 para. 1 WpHG on 7 December 2012, that on 4 December
2012 the share of voting rights in STRATEC Biomedical AG, Birkenfeld,
Germany, ISIN: DE0007289001 went above the threshold of 5% and that the
percentage of voting rights on that day amounted to 5.01% (587,453 voting
rights).
Ameriprise Financial, Inc. has notified us that these voting rights of
5.01% (587,453 voting rights) are attributable to Ameriprise Financial,
Inc. pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2
WpHG.
The voting rights were attributed to Ameriprise Financial, Inc. inter alia
from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or
more of the voting rights in STRATEC Biomedical AG.
10.12.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
---------------------------------------------------------------------------